Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG

doi:10.1084/jem.161.1.198

This Article

	Full Text (PDF, 756K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Taylor, H. P.
	Articles by Dimmock, N. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Taylor, H. P.
	Articles by Dimmock, N. J.


Social Bookmarking

	What's this?

ARTICLES

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG

HP Taylor and NJ Dimmock

We have found that bile is a useful source of secretory IgA (scIgA) which can specifically neutralize influenza virus infectivity. Using purified scIgA, we compared the mechanism of neutralization with that mediated by IgA monomers (prepared from scIgA by differential reduction) and IgG. At 4 degrees C, scIgA prevented the attachment of neutralized virus, while neither monomeric IgA nor IgG had any affect on this process or on the subsequent stages of infection by which virion RNA accumulates in nuclei. At 25 and 37 degrees C, scIgA permitted the attachment of approximately half the neutralized virus, but the virus was not internalized. Clearly, the neutralization depends on the character of the antibody used. scIgA may act by steric hindrance (with attachment or penetration, depending on temperature), whereas IgA and IgG neutralize infectivity at a stage subsequent to accumulation of the virus genome in the nucleus.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Robinson, K., Chamberlain, L. M., Lopez, M. C., Rush, C. M., Marcotte, H., Le Page, R. W. F., Wells, J. M. (2004). Mucosal and Cellular Immune Responses Elicited by Recombinant Lactococcus lactis Strains Expressing Tetanus Toxin Fragment C. Infect. Immun. 72: 2753-2761 [Abstract] [Full Text]
Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., Metzger, D. W. (2001). Fc Receptor-Mediated Phagocytosis Makes a Significant Contribution to Clearance of Influenza Virus Infections. J. Immunol. 166: 7381-7388 [Abstract] [Full Text]
Honorio-França, A. C., Launay, P., Carneiro-Sampaio, M. M. S., Monteiro, R. C. (2001). Colostral neutrophils express Fc{alpha} receptors (CD89) lacking {gamma} chain association and mediate noninflammatory properties of secretory IgA. J. Leukoc. Biol. 69: 289-296 [Abstract] [Full Text]
Stubbe, H., Berdoz, J., Kraehenbuhl, J.-P., Corthesy, B. (2000). Polymeric IgA Is Superior to Monomeric IgA and IgG Carrying the Same Variable Domain in Preventing Clostridium difficile Toxin A Damaging of T84 Monolayers. J. Immunol. 164: 1952-1960 [Abstract] [Full Text]
Weltzin, R., Monath, T. P. (1999). Intranasal Antibody Prophylaxis for Protection against Viral Disease. Clin. Microbiol. Rev. 12: 383-393 [Abstract] [Full Text]
Marcotte, H., Lavoie, M. C. (1998). Oral Microbial Ecology and the Role of Salivary Immunoglobulin A. Microbiol. Mol. Biol. Rev. 62: 71-109 [Abstract] [Full Text]
Renegar, K. B., Jackson, G. D. F., Mestecky, J. (1998). In Vitro Comparison of the Biologic Activities of Monoclonal Monomeric IgA, Polymeric IgA, and Secretory IgA. J. Immunol. 160: 1219-1223 [Abstract] [Full Text]
Lullau, E., Heyse, S., Vogel, H., Marison, I., von Stockar, U., Kraehenbuhl, J.-P., Corthesy, B. (1996). Antigen Binding Properties of Purified Immunoglobulin A and Reconstituted Secretory Immunoglobulin A Antibodies. J. Biol. Chem. 271: 16300-16309 [Abstract] [Full Text]
Reinholdt, J., Kilian, M. (1987). Interference of IgA Protease with the Effect of Secretory IgA on Adherence of Oral Streptococci to Saliva-coated Hydroxyapatite. JDR 66: 492-497 [Abstract]